Mutationsfabrikkerne.😂https://t.co/cS0s50rSCH
B.1.351'in nötralize edici titreleri önemli ölçüde azaldı. https://t.co/5yFshuLZht https://t.co/9HeG3zy4Sm
Birleşik Krallık Suşu olan B.1.1.7'nin nötralizasyonu, standart suşla karşılaştırıldığında ya benzerdi ya da çok az azaldı. https://t.co/jJLM1ya1jp https://t.co/9HeG3zfVEe
@jamie_weisman @SolidEvidence @CorneliusRoemer @LongDesertTrain @siamosolocani @JosetteSchoenma @rquiroga777 @TRyanGregory @EricTopol @ewencallaway @PeacockFlu @firefoxx66 All the additional Spike mutations here are outside the RBD, so the mAb sensitivity
The #COVID19 pandemic has had widespread effects across the globe, and its causative agent, #SARSCoV2 , continues to spread. Effective interventions need to be developed to end this #pandemic . Single and combination therapies.., Visit:https://t.co/SMUuz7
@kantei_vaccine 接種を阻止するのが官邸の責任! 追加接種すれば持続的な免疫抑制を招く 併せて 抗体依存性感染増強の危険性もある
@kantei_vaccine 無責任な事は止めて! 追加接種は 免疫を阻害する! また 変異に対して メリットは無い
@kantei_vaccine 無責任! 接種は即停止を! 今や 利はどこにあるのか? 追加接種で 感染増強抗体 が強化され❌ RBD抗体が意味をなさなくなった❌ 更に 昨年より警告❗️ /(Nature) ワクチン接種 中和活性 約1/10 ~1/12 https://t.co/OzS16A0tdp
RT @GolfingGolfingA: @takavet1 参院選の課題! 免疫アップ 促進! 接種は即停止を! 今や 追加接種で 感染増強抗体 が強化され RBD抗体が意味をなさなくなった 既に抗体に疑問視/昨年(Nature) 感染後 中和活性 約1/9…
@Matsukawa_Rui 参院は良識の府でしょ! まず 生命を大切に! 人の生命を阻害する 接種促進は大罪! 新型コロナワクチンは ワクチンにあらず! 追加接種で 感染を増強する抗体が強化され 抗体は意味を無くしたことが明らかに! 昨年の警鐘 ↓ 接種で中和活性は 約1/10 ~1/12 に減った https://t.co/OzS16Ai44X
@takavet1 参院選の課題! 免疫アップ 促進! 接種は即停止を! 今や 追加接種で 感染増強抗体 が強化され RBD抗体が意味をなさなくなった 既に抗体に疑問視/昨年(Nature) 感染後 中和活性 約1/9 に ワクチン接種 中和活性 約1/10 ~1/12 に https://t.co/OzS16Ai44X https://t.co/1WtJNQsBql
@wookashloo Nie, nie myślałeś, wydawało ci się. Także i to ci się wydawało, że podejmuję z tobą dyskusję. Jestem zwolennikiem tezy, że z idiotami się nie dyskutuje. Użyłem cię jako przykładu foliarza. I nic więcej. A badania masz tutaj: https://t.co/45cWK
@1crzydg @luckytran @davidhogg111 You're right... https://t.co/9GSgznXscT
10. So Regeneron's antibody cocktail also works very well as COVID-19 prophylaxis. This may be suitable for those who are the highest risk of severe COVID-19 (e.g. in immunocompromised) Data indicates these still works against SARS-CoV-2 variants https:/
RT @chiw00k: 안타까운 소식입니다. 지금 걱정스러운 코비드 바이러스 변종이 두 개가 있어요. 영국변종과 남아공변종이지요. 기존 코비드 바이러스에 면역이 생긴 사람들의 항체를 분석해 보니 영국변종에는 어느 정도 작용을 하는데 남아공변종에는 영…
@DocScurlock3 @BartMaes16 Dat weet ik niet, Marc. Richt je tot de mensen die deze bewoordingen in deze context in wetenschappelijke studies gebruiken. Hier nog een paar. Succes. https://t.co/rqxNCFvpl3 https://t.co/yaV3zN7nMl https://t.co/t1KePT1ZAF
@RyanWhatsOn1988 @PerpetualWinger @2GB873 As for which variants are vaccine resistant. This research is an interesting insight into virus mutations and the current and potential consequences for treatments and vaccines. https://t.co/8klk3D2ivP;
We’ve known for months https://t.co/IZUnHclK8h https://t.co/sgyf7nyncP https://t.co/YdbmuMxOTc that #SARSCoV2 Beta (B.1.351) has less susceptibility to antibody binding and neutralization. But does Beta influence the antibodies that are elicited by infect
RT @CryanGrim: Here I’ll even source the big study that scared the planet shitless https://t.co/wNmWZiEf0B
RT @kazuchancocone: @Subsub99999 @SE88668164 @pfK9ekBrfRcf1Tc @RaPzrhMkOsLaBwc ワクチンを打った人が不顕性感染し他者にうつしていることもわかっています。つまり、アフリカ株やデルタ株等の変異株の蔓延はワ…
@Subsub99999 @SE88668164 @pfK9ekBrfRcf1Tc @RaPzrhMkOsLaBwc ワクチンを打った人が不顕性感染し他者にうつしていることもわかっています。つまり、アフリカ株やデルタ株等の変異株の蔓延はワクチンがひとつの原因だと言えると思います。(ワクチンを打った人の体内で完全にウイルスを始末できていれば他者には感染させませんから。) https://t.co/MuCd2q0eEF
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 | Nature https://t.co/RlyJYdHa5Y
@MikeNewell11 @Cato1974 @ASlavitt And more.... https://t.co/C1FDAodfhH
すべてのサンプルでB.1.351に対する活性が失われていた。…中和活性の低下の程度は図4cでより明確になっている。全体として、…B.1.351に対する中和活性は有意に低かった(Modernaワクチンでは12.4倍、Pfizerワクチンでは10.3倍)。 https://t.co/9AsvRVzGUd https://t.co/HBIFi1E4TU
@DionysosPint @BumphBean @guardian Fresh eyes 👀 Clinical trial data show that the virus is traveling in a direction that is causing it to escape from our current vaccines and therapies that are directed against the viral spike. You are good at verbal gy
@MattGlantz @WAFoxen @dDeoxyribo @msalsberg Really? What about when the vaccines don't reduce transmission? Regardless, how anyone can say "everything the scientists know" is baffling. There are actually scientists stating the opposite... https://t.co/Cya
@Schnorri67 @TichysEinblick Wo die Reise hingeht ist auch klar. Dieser Artikel in Nature zeigt, dass sich das Virus in eine Richtung entwickelt welche Impfungen wirkungslos machen: https://t.co/R5F5lt8bWv Dass das Virus ausgerechnet in nicht geimpften so
We know that this variant is one of the most neutralising #antibody resistant variants we have seen so far https://t.co/MbiSTKnWa5
@arrola No se si entiendo el argumento. Que algo no haya pasado no significa que no pueda pasar. Además, ya hay varios estudios sobre el impacto de ciertas mutaciones existentes contra la vacuna. Me dejo algo? https://t.co/wRnRut9cBS https://t.co/tOZvBLQh4
@AliciaJWeston @Trump_ton @mattculluk @saffie @Gareth_Roberts_ More importantly, however, since current vaccines don't prevent infection, we've had high infection and vaccination rates simultaneously, leading to the evolution of resistant variants. E.g. ht
@ErikCumps @sjakie46390779 @Br_Christiaens @Roeloffzen1967 @Marc_Veld @lenigeliefde @cwitteveen1 @R137K @JurgenGeevels @sigridschollen @VandecaveyeN @MicrobiomDigest Het kan toch niet zo zijn dat een term ('resistance') die je in wetenschappelijke publicat
@SeanTynan @chrischirp Yes, https://t.co/rDML8RB7Z8: "compared to wild-type SARS-CoV-2, B.1.351 is markedly more resistant to neutralization by ... sera from individuals who have been vaccinated (10.3–12.4-fold)"... 1/
@MockDelbourne @HughDalton20 @zerocovidzoe "B.1.351 and emergent variants with similar mutations in the spike protein ... threaten the protective efficacy of current vaccines": https://t.co/rDML8RB7Z8
@MockDelbourne @HughDalton20 @zerocovidzoe See also https://t.co/rDML8RB7Z8: "compared to wild-type SARS-CoV-2, B.1.351 is markedly more resistant to neutralization by ... sera from individuals who have been vaccinated (10.3–12.4-fold)".
@TommySm03575785 @BBCNews Indeed it is rather less effective against variants: https://t.co/rDML8RB7Z8; https://t.co/movna3Xdbq. That's why we need #ZeroCovid.
@adx599 @garethrs19 @PoliticsPollss @dgurdasani1 @trishgreenhalgh @theAliceRoberts @Dr2NisreenAlwan @zerocovidzoe @cocobelladoodle You are denying the necessity of #ZeroCovid. As to vaccines, see https://t.co/rDML8RB7Z8. As scientists in New Zealand have s
RT @amrit_lohia: @talentedfergal @zerocovidzoe Remains to be seen. But certainly much more vaccine-resistant: e.g. https://t.co/rDML8RB7Z8…
@talentedfergal @zerocovidzoe Remains to be seen. But certainly much more vaccine-resistant: e.g. https://t.co/rDML8RB7Z8 and https://t.co/T3Pv3o4Bi8. As scientists in New Zealand have said, "If you are going to train a virus to escape vaccine-induced immu
@flambebae @PuckDontLie You mean like this: https://t.co/CD0kFuBf1e or this; https://t.co/XubwgAjs7J or this? https://t.co/1QWiOD0LCd
@AranLong1 @zerocovidzoe @cocobelladoodle @PsyberAttack See https://t.co/rDML8RB7Z8. Also, *everyone* is at risk of Long Covid: see e.g. https://t.co/Bufvurm1O3.
@randomperson_FA @pro_lockdown As you seem to acknowledge, they may reduce it but they don't stop transmission completely. So the virus can continue to infect vaccinated people, creating the perfect conditions for it to evolve resistance to vaccines. As ha
@boohoo07221632 @nightynouse @JMPSimor But see e.g. https://t.co/rDML8RB7Z8
@DrEricDing Select another track, please https://t.co/CouHDjbrtq
@DrKevinLynch1 @zerocovidzoe @devisridhar https://t.co/rDML8RB7Z8: "B.1.351 is markedly more resistant to neutralization by ... sera from individuals who have been vaccinated (10.3–12.4-fold) ... B.1.351 and ... variants with similar mutations in the spike
これは結構明るいニュースでした! 日本で流行ったイギリス株は抗体が効いて流行らなかった南アフリカ株はなかなか抗体が効かなかったみたいです。 SARS-CoV-2:B.1.351、B.1.1.7変異株は抗体による中和に強く抵抗することが実験室で判明した | Nature | Nature Portfolio: https://t.co/9nroXlWHM0
@SKM8370 @theAliceRoberts Are you stupid? https://t.co/rDML8RB7Z8 shows that B.1.351 is highly resistant, while B.1.1.7 is somewhat resistant. B.1.617 also appears to be quite resistant, given how fast it's spreading in the substantially vaccinated populat
#Cellimmunity #COVID19pandemic & research surrounding it is ongoing https://t.co/16gvF6SNhW https://t.co/Ch9i5adFm0 https://t.co/9BhMRK0G7e @Nature
RT @NatureJapan: Nature ハイライト:SARS-CoV-2の現在拡散中で懸念されている変異株に対する中和活性 | Nature https://t.co/ndGWEKJsHa #コロナウイルス #SARSCoV2 #変異株
RT @NatureJapan: Nature ハイライト:SARS-CoV-2の現在拡散中で懸念されている変異株に対する中和活性 | Nature https://t.co/ndGWEKJsHa #コロナウイルス #SARSCoV2 #変異株
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
RT @ColbenJill: The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are…
The virus is evolving to evade both current vaccines and monoclonal AB’s. Broad antivirals for tx, and natural immunity are gonna be the ticket. ⭐️TREAT EARLY, SAVE LIVES ⭐️ https://t.co/SVQPITTxuP
RT @alexvespi: Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 ‘B.1.1.7 is not more resistant to convalescent plasma or vac…
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130–135 (2021). - by Wang, P., Nair, M.S., Liu, L. et al. #COVID19 #COVID_19 https://t.co/5bmlvvtiNW
@jamiequint @LH This is the only argument I’ve heard that might have legs https://t.co/ss9U6e5cBz
@PussyMan_Dan @davemacladd "compared to wild-type SARS-CoV-2, B.1.351 is markedly more resistant to neutralization by ... sera from individuals who have been vaccinated (10.3–12.4-fold)": https://t.co/rDML8RB7Z8
@AranLong1 @zerocovidzoe https://t.co/rDML8RB7Z8: "compared to wild-type SARS-CoV-2, B.1.351 is markedly more resistant to neutralization by convalescent plasma (9.4-fold) and sera from individuals who have been vaccinated (10.3–12.4-fold)."
SARS-CoV-2の変異株B.1.351とB.1.1.7の抗体抵抗性 | Nature | Nature Portfolio: https://t.co/eBLIyBGZyX B.1.351変異株やスパイクタンパク質に類似の変異を持つ新興変異株は、モノクローナル抗体治療にとって新たな難問となり、また現在のワクチンの防御効果を脅かすだろう。
RT @olivenews: 野生型のSARS-CoV-2に比べると、B.1.351株は回復期血漿やワクチン既接種者由来血清による中和に対して、抵抗性が著しく高いことが分かった(前者に対しては9.4倍、後者に対しては10.3~12.4倍)。 SARS-CoV-2の変異株B.1…
RT @amrit_lohia: @JLWrangler79 @zerocovidzoe No, the Indian variant has many of the same mutations as the South African variant, and we kno…
@JLWrangler79 @zerocovidzoe No, the Indian variant has many of the same mutations as the South African variant, and we know vaccines don't work against that one: https://t.co/rDML8RB7Z8
RT @olivenews: 野生型のSARS-CoV-2に比べると、B.1.351株は回復期血漿やワクチン既接種者由来血清による中和に対して、抵抗性が著しく高いことが分かった(前者に対しては9.4倍、後者に対しては10.3~12.4倍)。 SARS-CoV-2の変異株B.1…
B.1.351(南ア型)が特にヤバそうだ。ワクチンが効かない可能性も。 https://t.co/vW5pHwnQyN
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 | Nature https://t.co/b32dgRi7Ty
RT @NatureJapan: Nature ハイライト:SARS-CoV-2の現在拡散中で懸念されている変異株に対する中和活性 | Nature https://t.co/ndGWEKJsHa #コロナウイルス #SARSCoV2 #変異株
Wang, P., Nair, M. S., Liu, L., Iketani, S., Luo, Y., Guo, Y., … Ho, D. D. (2021). Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. 𝘕𝘢𝘵𝘶𝘳𝘦. https://t.co/g0MBUjz7oa.
SARS-CoV-2:B.1.351、B.1.1.7変異株は抗体による中和に強く抵抗することが実験室で判明した | Nature | Nature Portfolio https://t.co/4579e4u5O7 @NatureJapan
RT @science_jp: コロナウイルス: SARS-CoV-2の現在拡散中で懸念されている変異株に対する中和活性 (Nature Research) https://t.co/AhXzGiO92F
RT @olivenews: 野生型のSARS-CoV-2に比べると、B.1.351株は回復期血漿やワクチン既接種者由来血清による中和に対して、抵抗性が著しく高いことが分かった(前者に対しては9.4倍、後者に対しては10.3~12.4倍)。 SARS-CoV-2の変異株B.1…
RT @olivenews: 野生型のSARS-CoV-2に比べると、B.1.351株は回復期血漿やワクチン既接種者由来血清による中和に対して、抵抗性が著しく高いことが分かった(前者に対しては9.4倍、後者に対しては10.3~12.4倍)。 SARS-CoV-2の変異株B.1…